"10.1371_journal.pone.0120012","plos one","2015-03-18T00:00:00Z","Kfir Oved; Asi Cohen; Olga Boico; Roy Navon; Tom Friedman; Liat Etshtein; Or Kriger; Ellen Bamberger; Yura Fonar; Renata Yacobov; Ron Wolchinsky; Galit Denkberg; Yaniv Dotan; Amit Hochberg; Yoram Reiter; Moti Grupper; Isaac Srugo; Paul Feigin; Malka Gorfine; Irina Chistyakov; Ron Dagan; Adi Klein; Israel Potasman; Eran Eden","MeMed Diagnostics, Tirat Carmel, Israel; Rambam Medical Center, Haifa, Israel; Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel; Department of Pediatrics, Hillel Yaffe Medical Center, Hadera, Israel; Department of Pediatrics, Bnai-Zion Medical Center, Haifa, Israel; Faculty of Biology, Technion-Israel Institute of Technology, Haifa, Israel; Applied Immune Technologies, Haifa, Israel; Department of Internal Medicine, Bnai-Zion Medical Center, Haifa, Israel; Infectious Diseases Unit, Bnai-Zion Medical Center, Haifa, Israel; Faculty of Industrial Engineering and Management, Technion-Israel Institute of Technology, Haifa, Israel; Pediatric Infectious Disease Unit and Clinical Microbiology Laboratory, Soroka Medical Center, Beer-Sheva, Israel","Conceived and designed the experiments: KO IP YR IS AK EE. Performed the experiments: OB TF LE OK YF RY RW GD YD AH MG IC. Analyzed the data: KO AC OB RN PF MG EE. Wrote the paper: KO AC EB MG IS PF RD IP EE. Interpretation of results: KO AC RN EB RD EE. Critically revised the manuscript: OB RN TF LE OK YF RY RW GD YD AH YR MG IC AK.","This study was funded by MeMed. KO, AC, OB, RN, TF, LE, EB and EE are employed by MeMed. TF and KO were previously employed by MeMed. Professors PF, IP, and YR report holding equity ownership or stock-options in MeMed. Drs. IC, YD, MG, and AH were part of the clinical expert panel and received hourly fees from MeMed. Prof. RD received consulting fees from MeMed. All MeMed affiliated authors hold stock options. GD is employed by Applied Immune Technologies. Dr. GD contributed to this work in her free time without any compensation from MeMed or Applied Immune Technologies. Drs. EE and KO have two related patents: WO 2011/132086 (Signatures and determinants for distinguishing between a bacterial and viral infection and methods of use thereof) and WO 2013/117746 (Signatures and determinants for diagnosing infections and methods of use thereof). MeMed has the following related products: ImmunoXpert™ and ImmunoPoC™ (in development). This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2015","03","Kfir Oved","KO",24,TRUE,6,12,7,9,TRUE,TRUE,FALSE,0,NA,FALSE
